Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Stoll

Showing results (361-370 of 377) with videos related to

Pageof 38
Sort By:
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
American Journal of Medical Genetics|July 11, 1997
The spectrum of congenital anomalies of the VATER association: an international studyL D Botto, M J Khoury, P Mastroiacovo, et al.
Neurobiology of Disease|July 6, 2019
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJoseph R Patterson, Megan F Duffy, Christopher J Kemp, et al.
NPJ Parkinson'S Disease|May 24, 2022
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJoseph R Patterson, Warren D Hirst, Jacob W Howe, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathologyJhodi M Webster, Ya-Ting Yang, Aidan T Miller, et al.
Neurobiology of Disease|February 26, 2026
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron lossJhodi M Webster, Ya-Ting Yang, Aidan T Miller, et al.
American Journal of Medical Genetics|October 26, 2000
9th international workshop on fragile X syndrome and X-linked mental retardationJ P Fryns, M Borghgraef, T W Brown, et al.
Pageof 38

Showing results (361-370 of 377) with videos related to

Sort By:
Pageof 38
Annales De Dermatologie Et De Venereologie|June 8, 2001
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|February 28, 2002
[Neurofibromatosis 1: recommendations for management]S Pinson, A Créange, S Barbarot, et al.
American Journal of Medical Genetics|July 11, 1997
The spectrum of congenital anomalies of the VATER association: an international studyL D Botto, M J Khoury, P Mastroiacovo, et al.
Neurobiology of Disease|July 6, 2019
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJoseph R Patterson, Megan F Duffy, Christopher J Kemp, et al.
NPJ Parkinson'S Disease|May 24, 2022
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJoseph R Patterson, Warren D Hirst, Jacob W Howe, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and neuropathologyJhodi M Webster, Ya-Ting Yang, Aidan T Miller, et al.
Neurobiology of Disease|February 26, 2026
Tau, amyloid-β and α-synuclein co-pathologies synergistically enhance neuroinflammation and hippocampal neuron lossJhodi M Webster, Ya-Ting Yang, Aidan T Miller, et al.
American Journal of Medical Genetics|October 26, 2000
9th international workshop on fragile X syndrome and X-linked mental retardationJ P Fryns, M Borghgraef, T W Brown, et al.
Pageof 38